Literature DB >> 7790076

Characterization of an antiproliferative surface-associated protein from Actinobacillus actinomycetemcomitans which can be neutralized by sera from a proportion of patients with localized juvenile periodontitis.

P A White1, M Wilson, S P Nair, A C Kirby, K Reddi, B Henderson.   

Abstract

The gentle agitation of suspensions of Actinobacillus actinomycetemcomitans serotype a, b, or c in saline resulted in the release of a proteinaceous surface-associated material (SAM) which produced a dose-dependent inhibition of tritiated thymidine incorporation by the osteoblast-like cell line MG63 in culture. This cell line was sensitive to low concentrations of SAM (50% inhibitory concentration, 200 ng/ml for serotype c). Immunoglobulin G antibodies to constituents of the SAM were found in the blood of patients with localized juvenile periodontitis (LJP). Sera from 9 of 16 patients with LJP significantly neutralized the antiproliferative activity of the SAM, while sera from 15 controls, with no evidence of periodontal disease, were unable to neutralize this activity. Neutralization was not directly related to the patient's antibody titer to the whole SAM. Characterization of the antiproliferative activity in the SAM demonstrated that it was not cytotoxic and was heat and trypsin sensitive. The active component separated in a well-defined peak in anion-exchange high-performance liquid chromatography (HPLC) which, when further analyzed by size exclusion HPLC, revealed a single active peak, which had an apparent molecular mass of approximately 8 kDa. The lipopolysaccharide from A. actinomycetemcomitans was only weakly active. SAM from Porphyromonas gingivalis W50 and Eikenella corrodens NCTC 10596 did not exhibit any antiproliferative activity with this cell line, even at concentrations as high as 10 micrograms/ml. This study has shown that SAM from A. actinomycetemcomitans contains a potent antiproliferative protein whose activity can be neutralized by antibodies in the sera from some patients with LJP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790076      PMCID: PMC173350          DOI: 10.1128/iai.63.7.2612-2618.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Frequency and stability of mono- or poly-infection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e.

Authors:  M Saarela; S Asikainen; S Alaluusua; L Pyhälä; C H Lai; H Jousimies-Somer
Journal:  Oral Microbiol Immunol       Date:  1992-10

2.  Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease.

Authors:  J J Zambon; T Umemoto; E De Nardin; F Nakazawa; L A Christersson; R J Genco
Journal:  Adv Dent Res       Date:  1988-11

3.  The comparative cytotoxicity of periodontal bacteria.

Authors:  R H Stevens; B F Hammond
Journal:  J Periodontol       Date:  1988-11       Impact factor: 6.993

4.  Suspected periodontopathic organisms alter in vitro proliferation of endothelial cells.

Authors:  N S Taichman; J E Klass; B J Shenker; E J Macarak; H Boehringer; C C Tsai
Journal:  J Periodontal Res       Date:  1984-11       Impact factor: 4.419

5.  Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease.

Authors:  J L Ebersole; M N Sandoval; M J Steffen; D Cappelli
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  Suppressive effect of soluble factor(s) derived from Prevotella loescheii ATCC 15930 on proliferation of human lymphocytes.

Authors:  N Terao; S Saito; M Hayakawa; Y Abiko
Journal:  Oral Microbiol Immunol       Date:  1992-08

7.  Anti-proliferative and cytotoxic activity of surface-associated material from periodontopathogenic bacteria.

Authors:  S Meghji; M Wilson; B Henderson; D Kinane
Journal:  Arch Oral Biol       Date:  1992-08       Impact factor: 2.633

8.  Higher-titer antisera from patients with periodontal disease inhibit bacterial capsule-induced bone breakdown.

Authors:  S Meghji; B Henderson; M Wilson
Journal:  J Periodontal Res       Date:  1993-03       Impact factor: 4.419

9.  Inhibition of fibroblast proliferation and collagen synthesis by capsular material from Actinobacillus actinomycetemcomitans.

Authors:  S Kamin; W Harvey; M Wilson; A Scutt
Journal:  J Med Microbiol       Date:  1986-11       Impact factor: 2.472

Review 10.  Actinobacillus actinomycetemcomitans in human periodontal disease.

Authors:  J J Zambon
Journal:  J Clin Periodontol       Date:  1985-01       Impact factor: 8.728

View more
  12 in total

1.  Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide antigen stimulates production of chemotactic factors and inflammatory cytokines by human monocytes.

Authors:  N Yamaguchi; Y Yamashita; D Ikeda; T Koga
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Authors:  M Sugai; T Kawamoto; S Y Pérès; Y Ueno; H Komatsuzawa; T Fujiwara; H Kurihara; H Suginaka; E Oswald
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

4.  Involvement of ganglioside GM3 in G(2)/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin.

Authors:  Koji Mise; Sumio Akifusa; Shinobu Watarai; Toshihiro Ansai; Tatsuji Nishihara; Tadamichi Takehara
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis.

Authors:  S Akifusa; S Poole; J Lewthwaite; B Henderson; S P Nair
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Cloning and expression of the Actinobacillus actinomycetemcomitans thioredoxin (trx) gene and assessment of cytokine inhibitory activity.

Authors:  B Henderson; P Tabona; S Poole; S P Nair
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  P Kelk; A Johansson; R Claesson; L Hänström; S Kalfas
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Subcellular localization and cytotoxic activity of the GroEL-like protein isolated from Actinobacillus actinomycetemcomitans.

Authors:  F Goulhen; A Hafezi; V J Uitto; D Hinode; R Nakamura; D Grenier; D Mayrand
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production.

Authors:  T Kurita-Ochiai; K Ochiai
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 10.  Aggregatibacter actinomycetemcomitans - a tooth killer?

Authors:  Manoj Raja; Fajar Ummer; C P Dhivakar
Journal:  J Clin Diagn Res       Date:  2014-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.